Inhalers are often used for asthma, a condition in which the lungs struggle to get enough air absorbed and sent to the body.
Respiratory specialists have shared tips for ensuring inhalers are used correctly in a bid to reduce the four deaths caused by asthma every day in the UK.
Add Yahoo as a preferred source to see more of our stories on Google. People using the popular corticosteroid inhalers Flovent HFA or Flovent Diskus to treat their asthma will need to switch to a new ...
Recently [Anthony Francis-Jones] decided to take a closer look at the inhaler that his son got prescribed for some mild breathing issues, specifically to teardown the mechanical counter on it.
Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA, a metered ...
EDITOR’S NOTE: Dr. Edith Bracho-Sanchez is a primary care pediatrician, director of pediatric telemedicine and assistant professor of pediatrics at Columbia University Irving Medical Center. Flovent, ...
Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...
Life-saving medicines used by millions of people in Britain, including insulin, asthma inhalers and weight-loss drugs, can lose effectiveness when exposed to warm temperatures ...
Miguel Divo, a lung specialist at Brigham and Women's Hospital in Boston, sits in an exam room across from Joel Rubinstein, who has asthma. Rubinstein, a retired psychiatrist, is about to get a ...
Concerns over health care’s carbon footprint typically revolve around issues like overly-air-conditioned hospitals and single-use medical supply waste. But researchers like Stanford University’s ...
Facing criticism over its pricing, Boehringer Ingelheim plans to cap out-of-pocket costs at $35 a month for its entire line of inhalers that are used to combat asthma and chronic obstructive pulmonary ...
GSK’s perpetual asthma inhaler updates have kept generics makers chasing a moving target for more than half a century, and it’s patients who are being forced to foot the bill, a new lawsuit filed in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results